Literature DB >> 15842589

Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.

Kevin A Waschke1, Alexandra-Chloe Villani, Severine Vermeire, Line Dufresne, Tsao-Chun Chen, Alain Bitton, Albert Cohen, Alan B R Thomson, Gary E Wild.   

Abstract

OBJECTIVES: Crohn's disease (CD) is a chronic multifactorial disorder with diverse clinical features that are influenced by a heterogeneous set of genetic factors. TNF-alpha/TNF receptor interactions play a pivotal role in the pathogenesis of the inflammatory response. Our purpose was to determine whether single nucleotide polymorphisms (SNPs) in the TNF receptors confer susceptibility to Crohn's disease and whether they are associated with clinical phenotype.
METHODS: A cohort of 205 consecutively identified and unrelated patients with CD and 106 controls were recruited. Subjects were genotyped for polymorphisms in TNFRSF1A (position +36, -609), TNFRSF1B (+196, +1466), along with the three common CARD15 variants and phenotyped for disease behavior. Genotypic and allelic frequencies were compared between CD and controls and a logistic regression model was constructed to determine independent associations with specific clinical phenotypes.
RESULTS: Only the TNFRSF1A +36 and TNFRSF1B +196 SNPs were associated with CD (p= 0.0019 and 0.034, respectively). The TNFRSF1A +36 mutation was negatively associated with stricturing disease phenotype (OR = 0.384; CI = 0.166-0.887). In contrast, the TNFRSF1B +196 was negatively associated with colitis (OR = 0.410; CI = 0.191-0.880). These associations were independent of CARD15 mutation status. Finally, TNFRSF1B +196 was negatively associated with surgery in CARD15 negative patients.
CONCLUSIONS: These data constitute the first report of an association of TNFRSF1A and TNFRSF1B polymorphisms with CD in a Caucasian population and address the role of TNFR mutations in determining clinical heterogeneity in CD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15842589     DOI: 10.1111/j.1572-0241.2005.40534.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  25 in total

1.  Structure-dependent functional properties of human defensin 5.

Authors:  Erik de Leeuw; Scott R Burks; Xiangqun Li; Joseph P Y Kao; Wuyuan Lu
Journal:  FEBS Lett       Date:  2007-01-02       Impact factor: 4.124

Review 2.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

Review 3.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.

Authors:  Bharat B Aggarwal; Subash C Gupta; Ji Hye Kim
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

4.  Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8(+) T Cells in Mice With Colitis.

Authors:  Shivesh Punit; Philip E Dubé; Cambrian Y Liu; Nandini Girish; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2015-06-11       Impact factor: 22.682

5.  TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.

Authors:  Liping Su; Sam C Nalle; Le Shen; Emily S Turner; Gurminder Singh; Lydia A Breskin; Ekaterina A Khramtsova; Galina Khramtsova; Pei-Yun Tsai; Yang-Xin Fu; Clara Abraham; Jerrold R Turner
Journal:  Gastroenterology       Date:  2013-04-22       Impact factor: 22.682

6.  Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand caucasian population.

Authors:  Lynnette R Ferguson; Dug Yeo Han; Claudia Huebner; Ivonne Petermann; Murray L Barclay; Richard B Gearry; Alan McCulloch; Pieter S Demmers
Journal:  Gastroenterol Res Pract       Date:  2009-05-03       Impact factor: 2.260

7.  Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort.

Authors:  Josef Wagner; Winnie H Sim; Justine A Ellis; Eng K Ong; Anthony G Catto-Smith; Donald J S Cameron; Ruth F Bishop; Carl D Kirkwood
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

8.  Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation.

Authors:  Cathy Lu; Alistair Waugh; Robert J Bailey; Raeleen Cherry; Levinus A Dieleman; Leah Gramlich; Kata Matic; Mario Millan; Karen I Kroeker; Daniel Sadowski; Christopher W Teshima; Dennis Todoruk; Clarence Wong; Karen Wong; Richard N Fedorak
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

9.  Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.

Authors:  Honggang Wang; Jianning Dong; Peiliang Shi; Jianhui Liu; Lugen Zuo; Yi Li; Jianfeng Gong; Lili Gu; Jie Zhao; Liang Zhang; Wei Zhang; Weiming Zhu; Ning Li; Jieshou Li
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

10.  The methionine 196 arginine polymorphism of the TNF receptor 2 gene (TNFRSF1B) is not associated with worse outcomes in heart failure.

Authors:  Charles F McTiernan; Ravi Ramani; Benjamin Burkhead; Dennis McNamara
Journal:  Cytokine       Date:  2012-08-24       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.